We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Ekf Diagnostics Holdings Plc | LSE:EKF | London | Ordinary Share | GB0031509804 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 27.40 | 27.10 | 28.60 | 27.40 | 27.40 | 27.40 | 260,265 | 16:21:02 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Med, Dental, Hosp Eq-whsl | 66.64M | -10.1M | -0.0222 | -12.34 | 124.65M |
Date | Subject | Author | Discuss |
---|---|---|---|
09/11/2020 12:07 | Ekf is virus agnostic. Their tubes should be part of the stockpile for future events. I see the income stream lasting for years especially when the inevitable enquiry begins and the benefits are outed. One of the few covid plays that won't be flash in the pan. | charlieej | |
09/11/2020 12:07 | Bagman - I don't give two hoots about "fullness of time". I trade short term and am +9% up already. Thank you all girls for your valuable "counter-indicator" feedback. That's some trading Wen! | tongosti | |
09/11/2020 11:57 | Only Mr Market is the Judge of that Joe. Watch this space Einstein. 1. Pfizer vaccine 90% effective. Think about implications (if you can of course) 2. Research you read is provided by corporate cheerleaders (aka storytellers) not people with skin in the game. Clearly, you do not have a clue how the City works. Good luck - you will need it | tongosti | |
09/11/2020 11:55 | At the obvious risk of continuing a pointless series of posts I decided a set of scales were needed: on the one side are the Company and research from N+1 Singer and on the other research from the esteemed Tongosti. To me there is a current imbalance but time will tell and until the story works out in real time and is factual maybe best if we stop telling each other what we have done and just carry on quietly. | welshborderer | |
09/11/2020 11:45 | Brave call Tongosti we will see in the fullness of time Lets see what the implications are with Moonshot we should know in the next 7 days as far as I can see EKF is the only one the Post office can transport but maybe I am missing something AIMHO GLA BTG | btgman | |
09/11/2020 11:34 | Some rookie a few days back said I must be short. No I wasn't after I cashed my long winnings. Now I have gone short! | tongosti | |
09/11/2020 11:32 | Worth noting too that they say the antibody test in conjunction with Kantaro to be launched in the new year should provide for further upgrade potential to the 2021 forecasts. | hastings | |
09/11/2020 11:10 | N+1 Singer: EKF has confirmed it expects a strong Q4 from both the core business and ongoing demand for the Primestore MTM sample collection device. As a result, FY20 performance is now expected to comfortably exceed market expectations, which have already been upgraded several times through the year. We upgrade our FY20 EBITDA forecasts by a further 6% to £24.4m and look forward to further updates in due course. EKF is a Best Idea for 2020 and we expect strong momentum to continue. | welshborderer | |
09/11/2020 10:58 | At the risk of ruining the fanclub's parade, the share'd better hold the opening level otherwise it might get quite ugly today. When the news is v bullish and Mr Market doesn't do what the crowd expects that's where v interesting trading opps take place. | tongosti | |
09/11/2020 09:06 | Odds for a meaningful (at least) major consolidation (or worse!) around existing levels have risen to 93% including last Friday's data. | tongosti | |
09/11/2020 08:57 | Am sure you have pal but pay attention to how the tape is reacting to it all. | tongosti | |
09/11/2020 08:57 | It was also a point JB mentioned at the AGM, that he'd rather benefit not just shareholders but also the greater community through EKF investment of spare cash in new health care companies. I presume investment(£5m or $5m?) in Trellus would be classified as intangible asset on the balance sheet, but Verici will now be a tangible asset value. | faz | |
09/11/2020 08:22 | I have touched on this before. Looking beyond the financial metrics, how does one value the agreement and relationship with Mount Sinai? This agreement and relationship provides EKF with advanced access to innovative commercial opportunities and presents significant opportunity for EKF to collaborate on ground breaking medical technologies that can be spun off and proceed down the IPO route. This has already resulted in shareholders benefiting from owning shares via a dividend in-specie in the spin off, Renalytix (£5) and now Verici(50p and in which EKF should have received 2,677,981 shares), and with Trellus Health now firmly in the wings too - If you were only focused on certain financial metrics, then you wouldn't have been invested here to have benefited from what is arguably difficult to measure, but a track record in terms of delivery is very encouraging to say the least! | wan | |
09/11/2020 08:02 | Great update indeed. MCAP £353m eFY PBT £11m puts it on a 30x earnings, so a little punchy (but I thought that was the case last time I sold and missed out on 20%). Good company in the right place, at the right time, with the right tech, that keep's upgrading it's estimates. Works for me ! GLA | hatfullofsky | |
09/11/2020 07:55 | Looking a little further out, 2021 is also shaping up to potentially provide another year of significant growth, with 'a number of new products' (not only Covid-19 related) adding wind to EKF's sails. Not to mention the continuation of dividends, and potentially in-specie dividends. | wan | |
09/11/2020 07:25 | YOY, revenues up circa 35% and EBITDA up over 100% (At this stage)! With no reference to ATM, along with the confidence being expressed (at this stage), I agree with Rivaldo, that there is potentially more in the tank! | wan | |
09/11/2020 07:22 | Exciting times all the previous expectations were based on orders to 30th September even now we still have over 50 days of orders to add on. Previous estimates were for 3.3p EPS for year end 5p looks on for year end 31st December. As Wan has eluded to you do wonder what the implications are for moonshot. AIMHO GLA BTG | btgman | |
09/11/2020 07:12 | Excellent indeed hastings :-)) | cheshire man | |
09/11/2020 07:09 | Lovely update once again - "comfortably ahead of market consensus". Great to see the core business now thriving, as well as PrimeStore. The fact that they feel they can state this with almost two months to go before the year end suggests there's still even more in the tank! | rivaldo | |
09/11/2020 07:03 | As expected an excellent TU this morning. | hastings | |
09/11/2020 00:21 | tongosti - filtered. Not so much for your views, but for the offensive and aggressive way in which you express them. Enough already. | pldazzle | |
08/11/2020 17:10 | V valuable info here on how crowded the long trade is on here. Thank you chaps - you're aces in my book. PS. Have seen the same exact behaviour from the crowd in other stocks (until their bubble bursts - after which they really start paying attention to one's contrarian view). | tongosti | |
08/11/2020 16:14 | as an avg joe I read thoroughly all the posts if news and/or valuable opinion. So you're filtered. | petewy | |
08/11/2020 12:45 | I didn't edit anything sport. It's just that you didn't read the whole post (that's what your typical avg Joe does) before replying. As for your strength of arguments please don't go there. You're just not good enough - you should read more and write less. | tongosti | |
08/11/2020 10:45 | Melody- I think his reason for selling was that the share price went down, and the share price movement proceeds (sic) fundamentals. I wanted to challenge him on this point; having initially replied fairly but brusquely he later went back & edited his point, accusing me of spreading BS on this board, thinking I wouldn’t notice the edit. Hence the filter. As said before I am really appreciative of the company & sector related info posted on here by highly respectable contributors & long may that continue. | firtashia |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions